Center for Bioactive Delivery


Nanosensors reported T cells (red) killing cancer cells (DAPI blue) in action. Nanosensors self-activated when in contact with cytotoxic proteins released from the T cells, lighting up green signal. Anh Nguyen, Chemical Engineering Department

The right drug to the right place Models for Optimized Drug delivery platforms

CBD creates new ways to deliver “The right drug to the right place: by creating novel delivery platforms for small and large molecules.”  Developing a wide range of delivery platforms matched to bioactive molecular delivery needs based on fundamental design principles, including nanoemulsions, nanoparticles, hybrid particles, bacteria, and hydrogels.

Bioactive delivery is a multi-dimensional challenge that remains a critical and often unsolved issue in product development. At the heart of CBD are organized multi-disciplinary teams focused on solutions to this complex landscape.

The long-term objective of the Center for Bioactive Delivery is to develop reliable, predictive models for optimized drug/carrier systems. This focus on synergies between the bioactive compound and its delivery for a suitable carrier solution creates a new paradigm for drug and nutrient delivery. 

The focus of our research falls into the following themes: